Showing results (51-60 of 200) with videos related to
Sort By:
Pageof 20
Plos One|February 12, 2014
Characterization of an Italian founder mutation in the RING-finger domain of BRCA1Laura Caleca, Anna Laura Putignano, Mara Colombo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 2015
Triple-Negative versus Non-Triple-Negative Breast Cancers in High-Risk Women: Phenotype Features and Survival from the HIBCRIT-1 MRI-Including Screening StudyFranca Podo, Filippo Santoro, Giovanni Di Leo, et al.Breast Cancer Research and Treatment|July 24, 2010
The CASP8 rs3834129 polymorphism and breast cancer risk in BRCA1 mutation carriersIrene Catucci, Paolo Verderio, Sara Pizzamiglio, et al.Breast Cancer Research and Treatment|April 25, 2012
Clinical and pathologic characteristics of BRCA-positive and BRCA-negative male breast cancer patients: results from a collaborative multicenter study in ItalyLaura Ottini, Valentina Silvestri, Piera Rizzolo, et al.Cancer Research|March 25, 2010
Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibilityMilena S Nicoloso, Hao Sun, Riccardo Spizzo, et al.Cancer Causes & Control : CCC|May 30, 2008
Infertility, treatment of infertility, and the risk of breast cancer among women with BRCA1 and BRCA2 mutations: a case-control studyJoanne Kotsopoulos, Clifford L Librach, Jan Lubinski, et al.Clinical Breast Cancer|January 4, 2023
Efficacy and Safety of First-line Carboplatin-paclitaxel and Carboplatin-gemcitabine in Patients With Advanced Triple-negative Breast Cancer: A Monocentric, Retrospective ComparisonRiccardo Lobefaro, Luigi Mariani, Giorgia Peverelli, et al.Journal of Medical Genetics|April 24, 2010
A BRCA1 promoter variant (rs11655505) and breast cancer riskPaolo Verderio, Sara Pizzamiglio, Melissa C Southey, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 16, 2008
Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study GroupKelly A Metcalfe, Jan Lubinski, Parviz Ghadirian, et al.Journal of the National Cancer Institute|September 25, 2008
Hormone therapy and the risk of breast cancer in BRCA1 mutation carriersAndrea Eisen, Jan Lubinski, Jacek Gronwald, et al.Pageof 20